NCT00165204View on ClinicalTrials.gov

Effects of Tibilone on Bone Density, Menopause Symptoms and Breast Density in Women After Prophylactic Oophorectomy

PHASE2CompletedINTERVENTIONAL
Enrollment

50

Participants

Timeline

Start Date

April 30, 2004

Primary Completion Date

March 31, 2006

Study Completion Date

March 31, 2006

Conditions
MenopausePostmenopausal Bone LossBreast Cancer
Interventions
DRUG

Tibolone

Trial Locations (3)

02114

Massachusetts General Hospital, Boston

02115

Dana-Farber Cancer Institute, Boston

02215

Beth Israel Deaconess Medical Center, Boston

All Listed Sponsors
collaborator

Brigham and Women's Hospital

OTHER

collaborator

Beth Israel Deaconess Medical Center

OTHER

collaborator

Massachusetts General Hospital

OTHER

collaborator

United States Department of Defense

FED

lead

Dana-Farber Cancer Institute

OTHER

NCT00165204 - Effects of Tibilone on Bone Density, Menopause Symptoms and Breast Density in Women After Prophylactic Oophorectomy | Biotech Hunter | Biotech Hunter